Aldawaa board OKs 6.3% cash dividend for Q4 2024
Aldawaa Medical Services Co.’s board decided today, May 18, the payment of a cash dividend at 6.3% of capital, or SAR 0.63 a share, for the fourth quarter of 2024, according to a statement to Tadawul.
Dividend Details (Q4 2024) |
|
Current Capital |
SAR 850 mln |
No. of Shares |
85 mln |
Total Dividend |
SAR 53.55 mln |
Percentage of Capital |
6.3% (SAR 0.63 a share) |
Record Date |
May 20, 2025 |
Payment Date |
June 3, 2025 |
Dividend Details (2024) |
|
Total Dividend |
SAR 213.78 mln |
Percentage of Capital |
25.15% (SAR 2.515 a share) |
Dividend History (SAR/share) Corporate Actions
Announcement | Ex-Dividend | Payment | Dividends (M Riyal) | Dividends * | Notes |
18/05/2025 | 20/05/2025 | 03/06/2025 | 53.55 | 0.63 | |
03/02/2025 | 10/02/2025 | 25/02/2025 | 53.55 | 0.63 | |
04/11/2024 | 11/11/2024 | 25/11/2024 | 53.55 | 0.63 | |
04/08/2024 | 11/08/2024 | 25/08/2024 | 53.13 | 0.63 | |
01/01/2024 | 12/02/2024 | 25/02/2024 | 106.25 | 1.25 | |
31/08/2023 | 11/09/2023 | 28/09/2023 | 106.25 | 1.25 | |
21/03/2023 | 05/04/2023 | 01/05/2023 | 106.25 | 1.25 | |
23/08/2022 | 05/09/2022 | 20/09/2022 | 106.25 | 1.25 |
Historical dividend per share adjusted for the effect of capital changes and bonus shares, if any
Dividend History
Consolidated cash dividend | Cash dividend per share (SAR) | * The stock price at the beginning of the period (SAR) | Return on the base price |
---|---|---|---|
Last 3 Financial years | 7.52 | 78.60 | 9.56 % |
Last 5 Financial years | N/A | N/A | N/A |
Last 10 Financial years | N/A | N/A | N/A |
Based on the beginning of the period (January 1 of the base year)
Comments {{getCommentCount()}}
Be the first to comment
{{Comments.indexOf(comment)+1}}
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}

Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.
Most Read
- SMC Healthcare executes largest hospital expansion in Northern Riyadh: CEO
- SABIC considers National Industrial Gases IPO: Report
- Jahez board plans 7.6M share buyback, statutory reserve transfer to retained earnings
- UCIC IPO 8.9x covered, 6 shares allocated
- Chemanol CEO steps down, Fares Al-Abbad appointed Acting CEO
Valuation Data (Latest Share Price)
P/E (TTM) | 17.90 |
P/E Before Unusual Items (TTM) | 17.90 |
P/BV | 4.54 |
Dividend Yield | 3.21 % |
Market Cap. (M) | 6,800.00 |
Return on Average Assets | 7.68 % |
Return on Average Equity | 27.18 % |
Call Request
Comments Analysis: